Eli Lilly Net Non-Operating Interest Income Expense (Quarterly) Trends

Eli Lilly & Co. (LLY)

1028.83 -13.32 (-1.28%) USD | NYSE | Feb 25, 16:00

1030.79 +1.96 (+0.19%) After-Hours: 20:00

View Net Non-Operating Interest Income Expense (Quarterly) for LLY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Biogen, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Viking Therapeutics, Inc.	Upgrade
Moderna, Inc.	Upgrade